China Pharma Holdings (CPHI) EBITDA Margin Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 304.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -157.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -650.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -3,172.00 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2,080.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 152.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -17,785.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -583.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2,472.00 |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | -367.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -367.00 |
| Dec 31, 2025 | 4,070.00 |
| Sep 30, 2025 | 1,054.00 |
| Jun 30, 2025 | 11,087.00 |
| Mar 31, 2025 | 288.00 |
| Dec 31, 2024 | -7,441.00 |
| Sep 30, 2024 | -4,995.00 |
| Jun 30, 2024 | -5,869.00 |
| Mar 31, 2024 | -5,755.00 |
| Dec 31, 2023 | -1,447.00 |
| Sep 30, 2023 | 3,153.00 |
| Jun 30, 2023 | -778.00 |
| Mar 31, 2023 | 4,716.00 |
| Dec 31, 2022 | -803.00 |
| Sep 30, 2022 | -2,702.00 |
| Jun 30, 2022 | -6,739.00 |
| Mar 31, 2022 | -2,540.00 |
| Dec 31, 2021 | -444.00 |
| Sep 30, 2021 | -2,120.00 |
| Jun 30, 2021 | -2,705.00 |